GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)

Symbol: PYXS on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$664,211	577,211	+32,703	+6%	$1.15	Q4 2025
30 Sep 2025	0%	+0%	$1,209,225	544,508	+33,545	+6.6%	$2.22	Q3 2025
30 Jun 2025	0%	-0%	$562,250	510,963	-598,135	-54%	$1.10	Q2 2025
31 Mar 2025	0%	+0%	$1,087,012	1,109,098	+26,649		$0.98	Q1 2025
31 Dec 2024	0%	0%	$1,688,948	1,082,449	-2,278	-0.21%	$1.56	Q4 2024
30 Sep 2024	0%	+0%	$3,981,570	1,084,727	+57,016	+5.5%	$3.67	Q3 2024
30 Jun 2024	0%	+0%	$3,401,994	1,027,711	+687,590	+202%	$3.31	Q2 2024
31 Mar 2024	0%	+0%	$1,449,252	340,121	+31,880	+10%	$4.26	Q1 2024
31 Dec 2023	0%	+0%	$554,964	308,241	+19,942	+6.9%	$1.80	Q4 2023
30 Sep 2023	0%	+0%	$573,873	288,299	+45,512	+19%	$1.99	Q3 2023
30 Jun 2023	0%	+0%	$621,534	242,787	+3,436	+1.4%	$2.56	Q2 2023
31 Mar 2023	0%	+0%	$959,797	239,351	+35,417	+17%	$4.01	Q1 2023
31 Dec 2022	0%	+0%	$273,000	203,934	+15,113	+8%	$1.34	Q4 2022
30 Sep 2022	0%	+0%	$371,000	188,821	+78,974	+72%	$1.96	Q3 2022
30 Jun 2022	0%	-0%	$261,000	109,847	-84,730	-44%	$2.38	Q2 2022
31 Mar 2022	0%	+0%	$786,000	194,577	+13,105	+7.2%	$4.04	Q1 2022
31 Dec 2021	0%	+0%	$1,990,000	181,472	+181,472	NEW	$10.97	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.